Suppr超能文献

较高的基线体重指数以及较低的估计中位数收入与子宫内膜癌诊断后体重指数增加相关。

Higher baseline BMI and lower estimated median income associated with increasing BMI after endometrial cancer diagnosis.

作者信息

Petersen Harrington Shariska, Balmaceda Julia, Spoozak Lori, Jewell Andrea, Fitzgerald-Wolff Sharon

机构信息

Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Kansas Medical Center, Kansas City, KS, United States.

University of Kansas School of Medicine, University of Kansas Medical Center, Kansas City, KS, United States.

出版信息

Gynecol Oncol Rep. 2022 Dec 13;44:101123. doi: 10.1016/j.gore.2022.101123. eCollection 2022 Dec.

Abstract

INTRODUCTION

Endometrial cancer is often directly related to obesity and interventions for weight loss have mixed results. Risk factors for continued weight gain after diagnosis are not clearly defined in the literature. The objective of this study is to describe risk factors associated with increased body mass index (BMI) trajectory among endometrial cancer patients.

METHODS

Patients who were surgically treated for endometrial cancer at a single institution between 2010 and 2015 were identified. Demographics including age, race/ethnicity and estimated median income at diagnosis were obtained. BMI at five time points after diagnosis were calculated. BMI trajectories were estimated by latent class growth modeling using the PROC TRAJ procedure in SAS. Chi-squared tests and ANOVA were used to assess differences between trajectory groups. Statistical significance was set to a p-value < 0.05.

RESULTS

Of 695 patients included in the study, the average age at diagnosis was 62 years and over 70% of patients were obese at baseline. Patients experienced increasing, stable, or decreasing BMI over 2 years following diagnosis. Patients with younger age and lower estimated median income were most likely to be in the increasing BMI group. Among obese patients, those with Class I obesity (BMI 30 to 34.9 kg/m) were most likely to experience decreasing BMI and those with Class III obesity (BMI > 40 kg/m) were most likely to experience increasing BMI, p < 0.0001.

CONCLUSION

A third of endometrial cancer survivors experience increasing BMI. Severity of obesity at diagnosis matters, patients with severe obesity (Class III) were most likely to experience weight gain.

摘要

引言

子宫内膜癌通常与肥胖直接相关,而减肥干预的效果参差不齐。文献中尚未明确诊断后体重持续增加的风险因素。本研究的目的是描述子宫内膜癌患者体重指数(BMI)轨迹增加相关的风险因素。

方法

确定2010年至2015年期间在单一机构接受子宫内膜癌手术治疗的患者。获取包括年龄、种族/民族以及诊断时估计的收入中位数等人口统计学数据。计算诊断后五个时间点的BMI。使用SAS中的PROC TRAJ程序通过潜在类别增长模型估计BMI轨迹。采用卡方检验和方差分析来评估轨迹组之间的差异。统计学显著性设定为p值<0.05。

结果

在纳入研究的695名患者中,诊断时的平均年龄为62岁,超过70%的患者在基线时肥胖。患者在诊断后的两年内BMI呈现上升、稳定或下降趋势。年龄较小且估计收入中位数较低的患者最有可能属于BMI上升组。在肥胖患者中,I类肥胖(BMI 30至34.9 kg/m)的患者最有可能BMI下降,而III类肥胖(BMI>40 kg/m)的患者最有可能BMI上升,p<0.0001。

结论

三分之一的子宫内膜癌幸存者BMI上升。诊断时肥胖的严重程度很重要,重度肥胖(III类)患者最有可能体重增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e904/9797639/693939b38599/gr1.jpg

相似文献

1
Higher baseline BMI and lower estimated median income associated with increasing BMI after endometrial cancer diagnosis.
Gynecol Oncol Rep. 2022 Dec 13;44:101123. doi: 10.1016/j.gore.2022.101123. eCollection 2022 Dec.
2
Higher baseline BMI and lower estimated median income is associated with increasing BMI after endometrial cancer diagnosis.
Gynecol Oncol Rep. 2022 Nov 24;44(Suppl 1):101109. doi: 10.1016/j.gore.2022.101109. eCollection 2022 Dec.
3
Adult lifetime body mass index trajectories and endometrial cancer risk.
BJOG. 2022 Aug;129(9):1521-1529. doi: 10.1111/1471-0528.17087. Epub 2022 Jan 18.
4
Body mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment.
Int J Gynecol Cancer. 2020 Feb;30(2):187-192. doi: 10.1136/ijgc-2019-000999. Epub 2019 Dec 15.
5
Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI.
Gynecol Oncol. 2016 Mar;140(3):405-8. doi: 10.1016/j.ygyno.2016.01.020. Epub 2016 Jan 20.
7
Quality of life in endometrial cancer survivors: single institution experience in Slovakia.
Health Qual Life Outcomes. 2020 Jul 10;18(1):221. doi: 10.1186/s12955-020-01474-1.
9
Severity of fetal growth restriction stratified according to maternal obesity.
J Matern Fetal Neonatal Med. 2022 May;35(10):1886-1890. doi: 10.1080/14767058.2020.1773427. Epub 2020 Jun 1.

本文引用的文献

1
Preventing Obesity in Midlife Women: A Recommendation From the Women's Preventive Services Initiative.
Ann Intern Med. 2022 Sep;175(9):1305-1309. doi: 10.7326/M22-0252. Epub 2022 Aug 2.
2
Cancer statistics, 2022.
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
3
Text-message-based behavioral weight loss for endometrial cancer survivors with obesity: A randomized controlled trial.
Gynecol Oncol. 2021 Sep;162(3):770-777. doi: 10.1016/j.ygyno.2021.06.007. Epub 2021 Jun 14.
5
Disparities in ovarian cancer survival at the only NCI-designated cancer center in Kansas.
Am J Surg. 2021 Apr;221(4):712-717. doi: 10.1016/j.amjsurg.2020.12.009. Epub 2020 Dec 7.
7
Knowledge of endometrial cancer risk factors in a general gynecologic population.
Gynecol Oncol. 2020 Jul;158(1):137-142. doi: 10.1016/j.ygyno.2020.03.032. Epub 2020 May 10.
8
A population-based study of cardiovascular disease mortality risk in US cancer patients.
Eur Heart J. 2019 Dec 21;40(48):3889-3897. doi: 10.1093/eurheartj/ehz766.
9
Cancer treatment and survivorship statistics, 2019.
CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验